Harvard Bioscience (HBIO) Exchange Rate Effect (2010 - 2026)
Harvard Bioscience's (HBIO) quarterly Exchange Rate Effect came in at -$225000.0 in Q1 2026, down 166.37% year-on-year from $339000.0 in Q1 2025, and down 623.26% on a QoQ basis from $43000.0 in Q4 2025.
Harvard Bioscience (HBIO) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Exchange Rate Effect data on file, last reported at -$225000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 166.37% year-over-year to -$225000.0 in Q1 2026; TTM through Mar 2026 was $367000.0, a 4.86% increase from a year earlier, with the FY2025 full-year figure at $931000.0, up 765.0% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$225000.0, down from $43000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for HBIO reached as high as $632000.0 in Q2 2025 and fell as low as -$363000.0 in Q4 2024.
- Historically, Exchange Rate Effect has averaged $12235.3 across 5 years, with a median of -$17000.0 in 2023.
- Across the five-year window, Exchange Rate Effect tumbled 337.5% in 2022 and jumped 15700.0% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$350000.0 in 2022, then soared by 47.71% to -$183000.0 in 2023, then sank by 98.36% to -$363000.0 in 2024, then soared by 111.85% to $43000.0 in 2025, then tumbled by 623.26% to -$225000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$225000.0 in Q1 2026, $43000.0 in Q4 2025, and -$83000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -16.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 7.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 1.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -7.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 2.58 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -1.60 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -3.00 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -2.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -6.39 Mn |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn | -225,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -225,000.00 |
| Mar 31, 2026 | -225,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Sep 30, 2025 | -83,000.00 |
| Sep 30, 2025 | -83,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Mar 31, 2025 | 339,000.00 |
| Mar 31, 2025 | 339,000.00 |
| Dec 31, 2024 | -363,000.00 |
| Dec 31, 2024 | -363,000.00 |
| Sep 30, 2024 | 370,000.00 |
| Sep 30, 2024 | 370,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | -151,000.00 |
| Mar 31, 2024 | -151,000.00 |
| Dec 31, 2023 | -183,000.00 |
| Dec 31, 2023 | -183,000.00 |